Theseus Pharmaceuticals Probability of Future Stock Price Finishing Under 3.71
| THRXDelisted Stock | USD 3.71 0.14 3.92% |
Theseus |
Theseus Pharmaceuticals Target Price Odds to finish below 3.71
The tendency of Theseus Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 3.71 | 90 days | 3.71 | near 1 |
Based on a normal probability distribution, the odds of Theseus Pharmaceuticals to move below current price in 90 days from now is near 1 (This Theseus Pharmaceuticals probability density function shows the probability of Theseus Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.14 . This usually implies Theseus Pharmaceuticals market returns are sensitive to returns on the market. As the market goes up or down, Theseus Pharmaceuticals is expected to follow. Additionally Theseus Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Theseus Pharmaceuticals Price Density |
| Price |
Predictive Modules for Theseus Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Theseus Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Theseus Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Theseus Pharmaceuticals is not an exception. The market had few large corrections towards the Theseus Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Theseus Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Theseus Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.69 | |
β | Beta against Dow Jones | 1.14 | |
σ | Overall volatility | 2.28 | |
Ir | Information ratio | -0.06 |
Theseus Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Theseus Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Theseus Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Theseus Pharmaceuticals is not yet fully synchronised with the market data | |
| Theseus Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (56.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Theseus Pharmaceuticals currently holds about 212.43 M in cash with (49.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.55, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 93.0% of the company shares are owned by institutional investors |
Theseus Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Theseus Stock often depends not only on the future outlook of the current and potential Theseus Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Theseus Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.5 M | |
| Cash And Short Term Investments | 198 M |
Theseus Pharmaceuticals Technical Analysis
Theseus Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Theseus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Theseus Pharmaceuticals. In general, you should focus on analyzing Theseus Stock price patterns and their correlations with different microeconomic environments and drivers.
Theseus Pharmaceuticals Predictive Forecast Models
Theseus Pharmaceuticals' time-series forecasting models is one of many Theseus Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Theseus Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Theseus Pharmaceuticals
Checking the ongoing alerts about Theseus Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Theseus Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Theseus Pharmaceuticals is not yet fully synchronised with the market data | |
| Theseus Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (56.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Theseus Pharmaceuticals currently holds about 212.43 M in cash with (49.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.55, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 93.0% of the company shares are owned by institutional investors |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |